New agreement between Xeptiva Therapeutics and the Institut Pasteur de Montevideo

On Decem­ber 21, 2023, Xeptiva signed an agree­ment with the Insti­tut Pasteur de Mon­te­v­ideo, making it a new partner of Xeptiva. This marks a major mile­stone in driving the devel­op­ment of our tech­nol­ogy, advanc­ing the company’s growth and attract­ing private capital.

The Insti­tut Pasteur de Mon­te­v­ideo is an insti­tu­tion ded­i­cated to sci­en­tific research in bio­log­i­cal medicine, con­sist­ing of high-tech sci­en­tific plat­forms, lab­o­ra­to­ries, an inter­na­tional teach­ing center and star­tups for the devel­op­ment of biotech­no­log­i­cal appli­ca­tions.

We are very excited about this col­lab­o­ra­tion, which will allow us to bring our tech­nol­ogy to the market.